DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ASSESSMENT OF CALCIUM DOBESILATE IN VARIED HYDROGEL COMPOSITIONS

被引:0
作者
Lisik, Anna [1 ]
Pilch, Ewa [1 ]
Slowiak, Laura [1 ]
Musial, Witold [1 ]
机构
[1] Wroclaw Med Univ, Pharmaceut Fac, Dept Phys Chem, Borowska 211, PL-50556 Wroclaw, Poland
来源
ACTA POLONIAE PHARMACEUTICA | 2018年 / 75卷 / 04期
关键词
calcium dobesilate; HPLC; validation; hydrogel; methylcellulose; DOUBLE-BLIND; METHYLCELLULOSE; DRUGS;
D O I
10.32383/appdr/77997
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Standardized analytical methods for testing pharmaceutical preparations are not readily available in the literature for calcium dohesilate hydrogels. The aim of the study was to develop and validate an analytical method for methylcellulose gel containing calcium dobesilate as an active ingredient. Samples from dissolution experiments were assessed via HPLC with UV-VIS detector. The optimal composition of mobile phase included acetonitrile with water 1 : 1, acidified to 2.5 pH value. The applied column was Standard Purospher Star 18e 250 x 4.6 (5 mu m), and the maximum wavelength was set at 240 nm, at 25 degrees V. The total run time of analysis was set at 5 min and acquired retention time was 2.7 and 3.1 min for calcium dobesilate depending on the hydrogel formulation. A validity study of the method revealed that all obtained calibration curves showed good linearity (r(2) > 0.9927). Eight different calcium dobesilate hydrogel formulations were tested. Linearity (100% level) was found to be 99 - 101% for all formulations. Trueness was in the range of 98-102% on three different spike levels for all eight formulations. Precision results were around 100% with RSD lower than 1% in all cases indicating that the method can be used as a validated method. Limit of quantitation (LOQ) was found to be 13.25 eg/mL for all eight formulations. The method is feasible for evaluation of hydrophilic gels with calcium dobesilate.
引用
收藏
页码:843 / 849
页数:7
相关论文
共 18 条
[1]  
[Anonymous], 2005, CELL METHOD, P20904
[2]   Calcium dobesilate for chronic venous insufficiency:: A systematic review [J].
Ciapponi, A ;
Laffaire, E ;
Roqué, M .
ANGIOLOGY, 2004, 55 (02) :147-154
[3]   Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease [J].
Flota-Cervera, Fernando ;
Flota-Ruiz, Cintia ;
Trevino, Carlos ;
Berber, Arturo .
ANGIOLOGY, 2008, 59 (03) :352-356
[4]   Hydrogel nanoparticles in drug delivery [J].
Hamidi, Mehrdad ;
Azadi, Amir ;
Rafiei, Pedram .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (15) :1638-1649
[5]   Agranulocytosis associated with calcium dobesilate -: Clinical course and risk estimation with the case-control and the case-population approaches [J].
Ibáñez, L ;
Ballarín, E ;
Vidal, X ;
Laporte, JR .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (9-10) :763-767
[6]  
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use, 1996, VAL AN PROC TEXT MET
[7]   Improving delivery of hydrophobic drugs from hydrogels through cyclodextrins [J].
Kanjickal, D ;
Lopina, S ;
Evancho-Chapman, MM ;
Schmidt, S ;
Donovan, D .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2005, 74A (03) :454-460
[8]   Effect of standard and reversible arrangements of Ph.Eur./USP extraction cells during dissolution tests of calcium dobesilate in hydrogel formulation [J].
Lisik, Anna ;
Wojcik-Pastuszka, Dorota ;
Twarda, Maria ;
Berkowski, Ryszard ;
Musial, Witold .
CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2015, 28 (02) :136-141
[9]   THE INFLUENCE OF DRUGS ON THE PROPERTIES OF GELS AND SWELLING CHARACTERISTICS OF MATRICES CONTAINING METHYLCELLULOSE OR HYDROXYPROPYLMETHYLCELLULOSE [J].
MITCHELL, K ;
FORD, JL ;
ARMSTRONG, DJ ;
ELLIOTT, PNC ;
HOGAN, JE ;
ROSTRON, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 100 (1-3) :165-173
[10]  
Moldoveanu S. C, SELECTION HPLC METHO, P1